Cohen Says He Is Encouraged By Eli Lilly COVID-19 Antibodies Study
September 19, 2020
An antibody drug study by Eli Lilly and Company has shown that the coronavirus antibody LY-CoV555, developed by Indianapolis-based Lilly and the Canadian company AbCellera, prevents mild to moderately ill coronavirus patients from being hospitalized. The antibody is reported to work by recognizing the virus once a person is infected...